Rang	Name	Position
1	Mr. James C. Clemmer	CEO, President & Director
2	Mr. Stephen A. Trowbridge	Executive VP & CFO
3	Mr. Lawrence T. Weiss	Senior VP, Chief Legal Officer & Corporate Secretary
4	Mr. Warren G. Nighan	Senior Vice President of Regulatory Affairs, Quality & Global Supply Chain
5	Ms. Laura Piccinini	Senior VP and GM of Cardiovascular & International
6	Mr. Saleem M. Cheeks	Vice President of Communications
7	Mr. Benjamin H. Davis	Senior Vice President of Business Development & Strategy
8	Ms. Marna I. Bronfen-Moore	Senior Vice President of Human Resources
9	Mr. Chad T. Campbell	Senior VP and GM of Oncology & Interventional Devices
10	Ms. Kim L. Seabury	Senior Vice President of Information Technology

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	8,92%	56,28 Mio. USD
2	Point72 Asset Management, L.P.	7,70%	48,59 Mio. USD
3	Systematic Financial Management LP	5,94%	37,47 Mio. USD
4	Armistice Capital, LLC	4,52%	28,54 Mio. USD
5	Broadfin Holdings LLC	4,40%	27,77 Mio. USD
6	Vanguard Capital Management, LLC	4,18%	26,37 Mio. USD
7	Royce & Associates, LP	3,70%	23,35 Mio. USD
8	Weber Capital Management LLC	3,28%	20,72 Mio. USD
9	State Street Corp	3,23%	20,37 Mio. USD
10	Bastion Asset Management Inc.	3,18%	20,05 Mio. USD
11	Nuveen, LLC	2,94%	18,57 Mio. USD
12	Geode Capital Management, LLC	2,38%	15,05 Mio. USD
13	Dimensional Fund Advisors, Inc.	2,35%	14,80 Mio. USD
14	Segall Bryant & Hamill	2,24%	14,15 Mio. USD
15	Pier Capital, LLC	1,95%	12,32 Mio. USD
16	Renaissance Technologies Corp	1,94%	12,27 Mio. USD
17	Millennium Management LLC	1,89%	11,96 Mio. USD
18	Arrowstreet Capital Limited Partnership	1,84%	11,58 Mio. USD
19	Paradigm Capital Management, Inc.	1,62%	10,25 Mio. USD
20	Divisadero Street Capital Management, LP	1,36%	8,58 Mio. USD